Adverse effects of antipsychotics

Respiratory disease, including infections, affects one in five people in England and is the third biggest cause of death, with around 68,000 annual deaths.In this podcast Dr Thomas Round talks to Professor Paul Little, a GP and Professor of Primary Care Research at the University ...  Show more

Irritable Bowel Syndrome (IBS) affects approximately 1 in 20 people in the UK, equating to around 3.2 million individuals, though some estimates suggest up to 1 in 5 adults experience symptoms, with potentially even more not seeking medical help. It's a common digestive disorder, ...  Show more

In this podcast, hear from Prof Hartmut Döhner, Hematologist-Oncologist and Professor of Medicine in Germany, as he discusses the growing roles of precise treatments based on the characteristics of the leukemic cells in acute myeloid leukemias. Discover the clinical developments ...  Show more

In the latest episode of the Psychiatry and Psychotherapy Podcast, Dr. Puder interviews Dr. Cummings, a psychopharmacologist. They discuss the way medicine works in our bodies, and if medicine or therapy is more effective for treating different disorders. They also talk about the ...  Show more

Episode 197 with Danielle Elliot.“I would love to see the conversation move towards less questioning of women when they talk about having ADHD.”Danielle is a health and science journalist, documentarian, and creator and host of Climbing the Walls, a new 6-part podcast series prod ...  Show more

In this episode of our pharmacology podcast, we take a deep dive into the pharmacology of levomilnacipran (Fetzima), a unique serotonin-norepinephrine reuptake inhibitor (SNRI) approved for the treatment of major depressive disorder (MDD) in adults. Designed for pharmacy students ...  Show more